GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
5.56
+0.49 (9.66%)
Oct 27, 2026, 11:59 AM EDT - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $10.03 million as of October 27, 2026. It is the 41,956th most valuable company in the world and the 5,653rd biggest in the United States. Its market cap has increased by 318.01% in one year.
Market Cap
10.03M
Enterprise Value
5.07M
1-Year Change
318.01%
Global Rank
Country Rank
#5,653 United States
Category
ChartMarket Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $10.03M, a decrease of -87.94%. That is a compound annual growth rate of -21.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 9.90M | 19.28% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 10.61M |
| BioLineRx | 10.58M |
| Palatin Technologies | 10.49M |
| Purple Biotech | 10.49M |
| IN8bio | 10.35M |
| Adial Pharmaceuticals | 10.29M |
| Phio Pharmaceuticals | 9.90M |
| BioVie | 9.35M |